Association of inflammatory blood markers and pathological complete response in HER2-positive breast cancer: a retrospective single-center cohort study
IBMs play a diverse predictive role in pCR in HER2-positive breast cancer stratified by neoadjuvant regimens. The combination of high MLR and high NLR enabled better identification of patients with poor responses to anti-HER2 therapy than high MLR or NLR alone.
Authors
- Chuan Wang (ORCID: https://orcid.org/0000-0002-4451-0788)
- Yuxiang Lin (ORCID: https://orcid.org/0000-0002-3963-3468)
- Fangmeng Fu (ORCID: https://orcid.org/0000-0002-3065-5708)
- Qindong Cai
- Jinqiao Wu (ORCID: https://orcid.org/0000-0003-3266-2554)
- Minyan Chen
- Yali Wang (ORCID: https://orcid.org/0009-0008-3685-8507)
- Lili Chen (ORCID: https://orcid.org/0000-0002-9965-8990)
- Li Yan (ORCID: https://orcid.org/0000-0002-4792-9998)
- Xiaobin Chen (ORCID: https://orcid.org/0000-0002-5664-3721)
- Hanxi Chen (ORCID: https://orcid.org/0009-0006-9460-4332)
- Lin Deng (ORCID: https://orcid.org/0009-0000-7420-8814)
- Xu Min (ORCID: https://orcid.org/0000-0001-7587-1992)
- Xin Tong (ORCID: https://orcid.org/0000-0001-5248-4770)
- Shunyi Liu
Institutions
- Fujian Medical University (CN)
- Union Hospital (CN)
- Third Hospital of Changsha (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-19
- DOI
- https://doi.org/10.3389/fimmu.2024.1465862
- Citations
- 5
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 1.41
Funders
- National Natural Science Foundation of China
- Fujian Medical University